Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nanexa | NANEXA | May 28, 2024 | 1.10 | +17.77 |
Nanologica | NICA | May 28, 2024 | 5.88 | -0.34 |
NextCell Pharma AB | NXTCL | May 28, 2024 | 3.80 | +171.80 |
Nykode Therapeutics | NYKDO | May 28, 2024 | 15.30 | +17.24 |
ODI Pharma | ODI | May 28, 2024 | 7.20 | -1.37 |
Oncopeptides | ONCO | May 28, 2024 | 2.85 | +5.95 |
OncoZenge | ONCOZ | May 28, 2024 | 3.44 | -1.71 |
OptiCept Technologies | OPTI | May 28, 2024 | 2.22 | +11.22 |
Orexo | ORX | May 28, 2024 | 21.25 | +8.42 |
OssDsign | OSSD | May 28, 2024 | 9.29 | +1.86 |
Peptonic Medical | PMED | May 28, 2024 | 0.01 | -7.02 |
PharmaLundensis | PHAL | May 28, 2024 | 0.62 | -21.32 |
Pila Pharma | PILA | May 28, 2024 | 2.83 | -2.08 |
Polymer Factory Sweden | POLYMER | May 28, 2024 | 0.70 | -5.37 |
Probi | PROB | May 28, 2024 | 231.00 | +11.06 |
Promimic AB | PRO | May 28, 2024 | 33.30 | -2.92 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | May 28, 2024 | 0.07 | -6.71 |
RaySearch Laboratories B | RAYB | May 28, 2024 | 139.20 | +0.14 |
Redwood Pharma | REDW | May 28, 2024 | 0.82 | -3.75 |
Respiratorius | RESP | May 28, 2024 | 0.10 | -6.41 |
Saniona | SANION | May 28, 2024 | 2.02 | +3.59 |
Scandinavian ChemoTech B | CMOTECB | May 28, 2024 | 2.01 | +1.26 |
Scandion Oncology | SCOL | May 28, 2024 | 0.68 | -2.86 |
Spago Nanomedical | SPAGO | May 28, 2024 | 0.26 | +6.88 |
Sprint Bioscience | SPRINT | May 28, 2024 | 1.21 | -7.76 |
Stayble Therapeutics | STABL | May 28, 2024 | 0.24 | -2.24 |
Stenocare | STENO | May 28, 2024 | 4.71 | -3.48 |
Swedish Orphan Biovitrum | SOBI | May 28, 2024 | 275.80 | -0.14 |
SynAct Pharma AB | SYNACT | May 28, 2024 | 7.03 | -0.28 |
Toleranzia | TOL | May 28, 2024 | 0.62 | -0.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.